baseline_question_id_by_improvement_plan_option_id.js

    var baseline_question_id_by_improvement_plan_option_id = {
      // Was a history and physical documented in the medical record?
      '4c570625b49164349b000002': '4c05a95eb491640c0600000e',
      // Is an AJCC stage in the medical record?
      '4c570625b49164349b000003': '4c05a95eb491640c06000011',
      // Is the pathology noted in the consultation note?
      '4c570625b49164349b000004': '4c05a95eb491640c06000015',
      // Was the intent of the treatment documented?
      '4c570625b49164349b000005': '4c05a95eb491640c06000015',
      // Was the treatment based upon clinical practice guidelines or published data?
      '4c570625b49164349b000006': '4c05a95eb491640c0600001e',
      // How many treatments were prescribed?
      '4c570625b49164349b000007': '4c05a95eb491640c06000022',
      // Was the case peer reviewed during the patient's course of treatment?
      '4c570625b49164349b000008': '4c05a95eb491640c0600002c',
      // Was IMRT used?
      '4c570625b49164349b000009': '4c05a95eb491640c0600002f',
      // Was there documentation in the medical record that the dose volume histogram (DVH) for the relevant normal tissue(s) was reviewed by a physician prior to treatment?
      '4c570625b49164349b00000a': '4c05a95eb491640c06000032',
      // Did a radiation oncologist review and approve the physics/dosimetry plan?
      '4c570625b49164349b00000b': '4c05a95eb491640c06000036',
      // Was patient-specific quality assurance conducted prior to treatment with IMRT or SRS/SBRT?
      '4c570625b49164349b00000c': '4c05a95eb491640c06000039',
      // Did the patient have routine imaging performed to verify positioning during treatment verification of set up performed of treated fields during treatment?
      '4c570625b49164349b00000d': '4c05a95eb491640c06000089',
      // Were there any unplanned treatment breaks greater than 3 fractions?
      '4c570625b49164349b00000e': '4c05a95eb491640c06000042',
      // Was a treatment summary communicated to members of the treatment team (medical oncologist, surgeon, primary care physician) within 30 days of completion of treatment?
      '4c570625b49164349b00000f': '4c05a95eb491640c06000045',
      // Was the patient only seen once for brachytherapy?
      '4c570625b49164349b000010': '4c44c98ef2c6db0f61000002',
      // Is there evidence in the medical record that the patient was informed of the risks of therapy?
      '4c570625b49164349b000011': '4c05a95eb491640c0600004a',
      // Was the patient screened for pain using a quantitative scale at the time of consultation?
      '4c570625b49164349b000012': '4c05a95eb491640c0600004d',
      // Did the patient have moderate to severe pain?
      '4c570625b49164349b000013': '4c44cfc8f2c6db0f8b000003',
      // Is there evidence that the patient had evaluation for acute symptoms during therapy?
      '4c570625b49164349b000014': '4c05a95eb491640c06000053',
      // Did the patient with prostate cancer have a documented evaluation of prostate-specific antigen (PSA), primary tumor (T) stage, and Gleason score?
      '4c570625b49164349b000015': '4c05a95eb491640c0600005e',
      // Did the low-risk cancer patient receiving interstitial prostate brachytherapy or external beam radiotherapy have a bone scan performed at any time since diagnosis of prostate cancer?
      '4c570625b49164349b000016': '4c05a95eb491640c06000063',
      // Was the high-risk prostate cancer patient receiving external beam radiotherapy prescribed adjuvant hormonal therapy (GnRH [gonadotropin-releasing hormone] agonist or antagonist)?
      '4c570625b49164349b000017': '4c05a95eb491640c0600006e',
      // Did the patient with clinically localized prostate cancer receiving interstitial prostate brachytherapy or external beam radiotherapy receive counseling on, at a minimum, the following treatment options for clinically localized disease: active surveillance, interstitial prostate brachytherapy, and external beam radiotherapy?
      '4c570625b49164349b000018': '4c05a95eb491640c06000069',
      // Did the patient with prostate cancer receiving external beam radiotherapy to the prostate only (no metastases) receive three-dimensional conformal radiotherapy (3D-CRT) or intensity modulated radiation therapy (IMRT)?
      '4c570625b49164349b000019': '4c05a95eb491640c06000074',
      // For permanent prostate implants, was post-implant dosimetry measured/reviewed?
      '4c570625b49164349b00001a': '4c05a95eb491640c06000077'
      }